Vyant Bio, Inc. (VYNT) has 13 open-market insider trades by 8 insiders since 2021. The most active filer is John A. Roberts, CEO.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| R. John Fletcher | Dir | — | 1 | $102K | 2023-01-17 |
| John A. Roberts | CEO | — | 3 | $85K | 2021-11-24 |
| Paul R. Hansen | Dir | — | 1 | $47K | 2023-01-17 |
| Andrew D.c. LaFrence | CFO | — | 2 | $20K | 2021-11-23 |
| Marcus Boehm | Dir | — | 1 | $8K | 2022-04-18 |
| Yung-Ping Yeh | Dir | — | 3 | $7K | 2022-03-30 |
| Robert Thomas Fremeau Jr. | Chief Scientific Officer | — | 1 | $2K | 2021-10-28 |
| Geoffrey E. Harris | Dir | — | 1 | $1K | 2023-01-17 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Geoffrey E. Harris | Director | Sell | $1K | 2022-11-18 |
| Marcus Boehm | Director | Buy | $8K | 2021-12-06 |
| John A. Roberts | CEO | Buy | $10K | 2021-11-24 |
| Andrew D.c. LaFrence | CFO | Buy | $10K | 2021-11-23 |
| Yung-Ping Yeh | Chief Innovation Officer | Buy | $1K | 2021-11-22 |
| Robert Thomas Fremeau Jr. | Chief Scientific Officer | Buy | $2K |
Companies that share insiders with VYNT, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2021-10-28 |
| Marcus Boehm | Director | Buy | $11K | 2021-10-27 |
| Marcus Boehm | Director | Buy | $12K | 2021-09-29 |
| Marcus Boehm | Director | Buy | $13K | 2021-08-25 |
| Yung-Ping Yeh | Chief Innovation Officer | Buy | $3K | 2021-08-25 |
| John A. Roberts | CEO | Buy | $25K | 2021-08-23 |
| Paul R. Hansen | Director | Buy | $47K | 2021-08-19 |
| Marcus Boehm | Director | Buy | $15K | 2021-07-28 |
| Marcus Boehm | Director | Buy | $19K | 2021-06-30 |
| Marcus Boehm | Director | Buy | $18K | 2021-05-28 |